Opioid sparing anesthesia for bariatric surgery

Perioperative opioid sparing effect of erector spinae plane block and intravenous dexmedetomidine for patients with obstructive sleep apnea undergoing bariatric surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR201911712319290

Enrollment

Registered

2019-11-12

Start date

2019-11-15

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Anaesthesia

Interventions

erector spinae plane block and intravenous dexmedetomidine

general anesthesia only

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: fourty patients aged 20-55 years old both sex body mass index at least 35 kg/m2 ASA II with obstructive sleep apnea (use nocturnal CPAP ventilation regularly) eligible for elective laparoscopic bariatric surgery

Exclusion criteria

Exclusion criteria: patient refusal lactating female use of opioid for chronic pain or drug abuse allergy or contraindication to any of the used drugs uncontrolled diabetes mellitus or hypertension unstable cardiopulmonary dysfunction, renal or hepatic insufficiency,

Design outcomes

Primary

Measure	Time frame
postoperative opioid requirements	—

Secondary

Measure	Time frame
number of patients need extra fentanyl consumption other than that of induction of anesthesia;heart rate;mean arterial blood pressure;pain score;recovery time;adverse effects;time to first analgesic request postoperative	—

Countries

Egypt

Contacts

Public ContactAtteia Anwar

Assistant professor

atteiagad@gmail.com+201025547544

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026